Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;52(6):1996-2017.
doi: 10.1111/1475-6773.12788.

Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs

Adam A Markovitz  1   2   3 , Rob G Holleman  1 , Timothy P Hofer  1   2   4 , Eve A Kerr  1   2   4 , Mandi L Klamerus  1 , Jeremy B Sussman  1   2   4
Affiliations

Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs

Adam A Markovitz et al. Health Serv Res. 2017 Dec.

Abstract

Objective: To compare the effects of two sequential policy changes-the addition of a high-potency statin to the Department of Veterans Affairs (VA) formulary and the release of the American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines-on VA provider prescribing.

Data sources/study setting: Retrospective analysis of 1,100,682 VA patients, 2011-2016.

Study design: Interrupted time-series analysis of changes in prescribing of moderate-to-high-intensity statins among high-risk patients and across high-risk subgroups. We also assessed changes in prescribing of atorvastatin and other statin drugs. We estimated marginal effects (ME) of formulary and guideline changes by comparing predicted and observed statin use.

Data collection/extraction methods: Data from VA Corporate Data Warehouse.

Principal findings: The use of moderate-to-high-intensity statins increased by 2 percentage points following the formulary change (ME, 2.4, 95% confidence interval [CI], 2.2 to 2.6) and less than 1 percentage point following the guideline change (ME, 0.8, 95% CI, 0.6 to 0.9). The formulary change led to approximately a 12 percentage-point increase in the use of moderate-to-high-intensity atorvastatin (ME, 11.5, 95% CI, 11.3 to 11.6). The relatively greater provider response to the formulary change occurred across all patient subgroups.

Conclusions: Addition of a high-potency statin to formulary affected provider prescribing more than the ACC/AHA guidelines.

Keywords: Veterans Affairs; cardiovascular disease; pharmaceuticals; provider interventions; quality of care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in Prescribing of Moderate‐to‐High‐Intensity Statins among High‐Risk Patients in the Veterans Affairs (2011–2016) [Color figure can be viewed at wileyonlinelibrary.com]
Figure 2
Figure 2
Trends in Prescribing of Specific Statin Drugs in the Veterans Affairs, by ACC/AHA Risk Group (2011–2016) [Color figure can be viewed at wileyonlinelibrary.com]
See this image and copyright information in PMC

References

    1. Arnold, S. V. , Spertus J. A., Tang F., Krumholz H. M., Borden W. B., Farmer S. A., Ting H. H., and Chan P. S.. 2011. “Statin Use in Outpatients with Obstructive Coronary Artery Disease.” Circulation 124: 2405–10. - PMC - PubMed
    1. Ballinger, G. A. 2004. “Using Generalized Estimating Equations for Longitudinal Data Analysis.” Organizational Research Methods 7: 127–50.
    1. Bhaskaran, K. , Gasparrini A., Hajat S., Smeeth L., and Armstrong B.. 2013. “Time Series Regression Studies in Environmental Epidemiology.” International Journal of Epidemiology 42: 1187–95. - PMC - PubMed
    1. Cabana, M. D. , Rand C. S., Powe N. R., Wu A. W., Wilson M. H., Abboud P.‐A. C., and Rubin H. R.. 1999. “Why Don't Physicians Follow Clinical Practice Guidelines?” Journal of the American Medical Association 282: 1458–65. - PubMed
    1. Department of Veterans Affairs . 2017. “Health Benefits” [accessed on May 7, 2017]. Available at https://www.va.gov/healthbenefits/resources/priority_groups.asp

MeSH terms

Substances